The Rimonabant in the use of prediabetes study.

Trial Profile

The Rimonabant in the use of prediabetes study.

Completed
Phase of Trial: Phase III

Latest Information Update: 31 Oct 2011

At a glance

  • Drugs Rimonabant (Primary)
  • Indications Glucose intolerance
  • Focus Therapeutic Use
  • Acronyms TRIMTOP
  • Most Recent Events

    • 24 Sep 2010 Actual end date (27 Sep 2008) indentified as reported by United Kingdom Clinical Research Network record.
    • 24 Sep 2010 Status changed from suspended to completed as reported by United Kingdom Clinical Research Network record.
    • 09 Jul 2010 Status changed from recruiting to suspended as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top